These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11965033)

  • 1. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
    Ensminger SM; Spriewald BM; Witzke O; Morrison K; Pajaro OE; Morris PJ; Rose ML; Wood KJ
    Transplantation; 2002 Apr; 73(7):1068-74. PubMed ID: 11965033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect allorecognition can play an important role in the development of transplant arteriosclerosis.
    Ensminger SM; Spriewald BM; Witzke O; Pajaro OE; Yacoub MH; Morris PJ; Rose ML; Wood KJ
    Transplantation; 2002 Jan; 73(2):279-86. PubMed ID: 11821744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
    Spriewald BM; Ensminger SM; Bushell A; Wood KJ
    Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
    Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
    Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells.
    Ensminger SM; Spriewald BM; Witzke O; Morrison K; van Maurik A; Morris PJ; Rose ML; Wood KJ
    Transplantation; 2000 Sep; 70(6):955-63. PubMed ID: 11014649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
    Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
    J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model.
    Heim C; Abele-Ohl S; Eckl S; Ramsperger-Gleixner M; Mahmoudian S; Weyand M; Stamminger T; Ensminger SM
    Transplantation; 2010 Aug; 90(4):373-9. PubMed ID: 20585280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts.
    Abele S; Spriewald BM; Ramsperger-Gleixner M; Wollin M; Hiemann NE; Nieswandt B; Weyand M; Ensminger SM
    Transplantation; 2009 Jan; 87(2):207-16. PubMed ID: 19155974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
    Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
    Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of transplant arteriosclerosis after treatment with mycophenolate mofetil and ganciclovir in a mouse aortic allograft model.
    Hoffmann J; Böhm M; Abele-Ohl S; Ramsperger-Gleixner M; Spriewald BM; Zinser E; Steinkasserer A; Weyand M; Ensminger SM
    Exp Clin Transplant; 2012 Dec; 10(6):592-600. PubMed ID: 23110396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.
    Heim C; Bernhardt W; Jalilova S; Wang Z; Motsch B; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
    Interact Cardiovasc Thorac Surg; 2016 May; 22(5):561-70. PubMed ID: 26819270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis.
    Ensminger SM; Spriewald BM; Steger U; Morris PJ; Mak TW; Wood KJ
    Transplantation; 2002 Nov; 74(9):1267-73. PubMed ID: 12451264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
    Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
    Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal-sequence-deleted major histocompatibility complex class-I alloantigen can induce specific immunologic unresponsiveness in vivo.
    Spriewald BM; Billing JS; Jenkins S; Wheeler P; Steger U; Bushell A; Hyde K; Morris PJ; Wood KJ
    Transplantation; 2003 Feb; 75(4):537-41. PubMed ID: 12605123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
    Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
    Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.